ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Research report covers the CRISPR and CRISPR-Associated (Cas) Genes Market Forecasts and Growth, 2017 – 2025 – Medgadget (blog)

Continue reading

2017-03-01 Michael Zand NEWS

Broad Institute of MIT and Harvard to receive European patent for CRISPR-Cpf1 – pharmabiz.com

Broad Institute of MIT and Harvard to receive European patent for CRISPR-Cpf1pharmabiz.comCRISPR-Cpf1 holds the potential for simpler and more precise genome engineering than has been available with CRISPR-Cas9. Feng Zhang and collaborators elucidated … Continue reading

2017-03-01 Michael Zand NEWS

Celyad to Present at Cowen and Company 37th Annual Health Care Conference – Yahoo Finance

Research report covers the CRISPR and CRISPR-Associated (Cas) Genes Market Forecasts and Growth, 2017 – 2025
Medgadget (blog)
In the past few years research and development of CRISPR or clustered regularly interspaced short palindromic repeats has allowed molecular biologists to designs solutions for repairing cells by genome editing. This method allows a change to a specific …

Continue reading

2017-03-01 Michael Zand NEWS

Gene therapy to fight a blood cancer succeeds in major study – The Denver Post

Celyad to Present at Cowen and Company 37th Annual Health Care Conference
Yahoo Finance
The Company utilizes its expertise in cell engineering to target cancer. Celyad’s Natural Killer Receptor based T–Cell (NKR-T) platform has the potential to treat a broad range of solid and hematologic tumors. Its lead oncology candidate, the CAR-T NKR …

and more »

Continue reading

2017-03-01 Michael Zand NEWS

Gene therapy to fight a blood cancer succeeds in major study – The Denver Post


The Denver Post

Gene therapy to fight a blood cancer succeeds in major study
The Denver Post
An experimental gene therapy that turns a patient’s own blood cells into cancer killers worked in a major study, with more than one-third of very sick lymphoma patients showing no sign of disease six months after a single treatment, its maker said Tuesday.
Terminal cancer patients in complete remission after one gene therapy treatmentTelegraph.co.uk
Gene Therapy Shows Promise for Aggressive LymphomaEveryday Health (blog)
Gene Therapy Study Brings 36 Percent Complete RemissionAmerica Now
The Times (subscription)
all 98 news articles »
Continue reading

2017-03-01 Michael Zand NEWS

Synthetic Biology Market Expected to Register High Revenue Growth Through 2024 – Medgadget (blog)

Synthetic Biology Market Expected to Register High Revenue Growth Through 2024Medgadget (blog)Synthetic biology deals with the design and construction of new biological entities. It is an interdependent combination of biology and engineering for the co… Continue reading

2017-03-01 Michael Zand NEWS

Synthetic Biology Market Expected to Register High Revenue Growth Through 2024 – Medgadget (blog)

Synthetic Biology Market Expected to Register High Revenue Growth Through 2024Medgadget (blog)Synthetic biology deals with the design and construction of new biological entities. It is an interdependent combination of biology and engineering for the co… Continue reading

2017-03-01 Michael Zand NEWS

Synthetic biology: Emerging technology in food industry – fnbnews.com

Synthetic biology: Emerging technology in food industryfnbnews.comSynthetic Biology is an emerging technology that is expanding the tools available to researchers and scientists to engineer organisms for wide range of applications. With interface of bi… Continue reading

2017-03-01 Michael Zand NEWS
  • 1
  • …
  • 2,036
  • 2,037
  • 2,038
  • 2,039
  • 2,040
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

The Denver Post

Gene therapy to fight a blood cancer succeeds in major study
The Denver Post
An experimental gene therapy that turns a patient’s own blood cells into cancer killers worked in a major study, with more than one-third of very sick lymphoma patients showing no sign of disease six months after a single treatment, its maker said Tuesday.
Terminal cancer patients in complete remission after one gene therapy treatmentTelegraph.co.uk
Gene Therapy Shows Promise for Aggressive LymphomaEveryday Health (blog)
New gene therapy ‘shrinks tumours like ice cubes’The Times (subscription)
America Now
all 98 news articles »